Biomedical subjects
D A Manigot
Publications and source records attributed to D A Manigot.
[AIDS and Chagas: the difficulty of globalizing protocols].
Explore the source record for details and available documents.
[The dilemma of cancer therapy and the oncologist-patient relationship].
Explore the source record for details and available documents.
[Thymectomy and myasthenia gravis].
Explore the source record for details and available documents.
[Precordial pain and chronic Chagas disease].
Explore the source record for details and available documents.
Immunoglobulin A antibodies to Trypanosoma cruzi antigens in digestive forms of Chagas' disease.
In an attempt to find a serological marker for the diagnosis of chronic digestive forms of Chagas' disease, we compared amastigote and trypomastigote antigens obtained from immunosuppressed mice infected with Trypanosoma cruzi (Y strain) with conventional epimastigote antigens to search for immunoglobulin A (IgA) antibodies. A total of 255 serum samples from patients with acute and chronic (indeterminate, digestive, and cardiac) forms of Chagas' disease and with nonchagasic diseases and from healthy individuals were studied. Amastigote antigens proved to be the most adequate for our purpose, since IgA antibodies could be detected in 23 of 25 serum samples from patients with digestive forms, with relative indices of sensitivity, specificity, and efficiency of 0.920, 0.911, and 0.912, respectively. These antigens also showed high reactivity with IgA antibodies, with a geometric mean titer of 16,635 (12.7 log2). IgA antibodies were detected in 16 of 28 serum samples from patients with the acute form as well, but this clinical form is easily distinguished from the chronic form by the demonstration of IgM antibodies. Poor results were seen with trypomastigote and epimastigote antigens. The finding of IgA antibodies in about 20% of indeterminate forms and 20% of cardiac forms, although in low titers, requires further investigation to ascertain their role as an early signal of gastrointestinal lesions. In addition, the amastigote antigens described here seem more convenient for use in endemic areas than those obtained from cell cultures because of their lower cost.
[Chronic Chagas' cardiopathy in endemic zones].
Explore the source record for details and available documents.
[Benznidazole and chronic Chagas disease].
Explore the source record for details and available documents.
[Chagas disease caused by transfusion and immunosuppressive therapy].
Explore the source record for details and available documents.
The direct agglutination test for chronic Chagas's disease. The effect of pre-treatment of test samples with 2-mercaptoethanol.
The relative sensitivity and relative specificity of the direct agglutination (DA) test for the diagnosis of human Trypanosoma cruzi infection were studied in human serum samples, with and without previous treatment with 2-mercaptoethanol (2-ME), which were obtained from different areas of Brazil. Results obtained with these tests were related to those obtained with the indirect immunofluorescence (IIF) and indirect haemagglutination (IHA) tests. The DA test results from the sample not previously treated with 2-ME did not agree with those from the IIF and IHA tests. On the other hand, the DA test results from the sample previously treated with 2-ME agreed significantly (99.22%) with those from the IIF and IHA tests.
[Ventricular tachycardia caused by the use of amiodarone. Report of a case].
Explore the source record for details and available documents.
[Amiodarone as an antiarrhythmia drug - study using the exercise test].
Explore the source record for details and available documents.
[Vascular endothelial and peripheral nerve antibodies in chronic Chagas' infection. Study of patients with different clinical forms].
Explore the source record for details and available documents.